HDAC9 and cancer: Given the fact that NIS is also normally expressed, to various extents, in several non-thyroid tissues, in the present study we tested NIS expression and radioiodine uptake in cancer cells derived from non-thyroid tissues by simultaneously suppressing the MAP kinase and PI3K/Akt pathways and HDAC.